Adverse Mental, Behavioral Health Issues Common During COVID-19
THURSDAY, Aug. 13, 2020 -- More than 40 percent of adults across the United States have reported at least one adverse mental or behavioral health condition during the COVID-19 pandemic, according to research published in the Aug. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Mark É. Czeisler, from the Turner Institute for Brain and Mental Health at Monash University in Melbourne, Australia, and colleagues conducted representative panel surveys among adults aged ≥18 years across the United States during June 24 to 30, 2020, to assess mental health, substance use, and suicidal ideation during the pandemic.
The researchers found that 40.9 percent of respondents reported at least one adverse mental or behavioral health condition; these included anxiety disorder or depressive disorder symptoms (30.9 percent), symptoms of a trauma- and stressor-related disorder related to the pandemic (26.3 percent), and having started or increased substance use to cope with COVID-19-related stress or emotions (13.3 percent). The proportion of respondents who reported having seriously considered suicide in the previous 30 days was increased for those aged 18 to 24 years (25.5 percent), minority racial/ethnic groups (Hispanic respondents: 18.6 percent; non-Hispanic black respondents: 15.1 percent), self-reported unpaid caregivers for adults (30.7 percent), and essential workers (21.7 percent) compared with all respondents (10.7 percent).
"Addressing mental health disparities and preparing support systems to mitigate mental health consequences as the pandemic evolves will continue to be needed urgently," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: August 2020
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup...
FRIDAY, Sept. 25, 2020 -- Non-English speakers are less likely to have completed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and have a higher proportion...
FRIDAY, Sept. 25, 2020 -- Fertility treatment suspensions due to the COVID-19 pandemic have had a considerable negative impact on women's mental health and quality of life,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.